- News Home
24 April 2014 11:45 am ,
Vol. 344 ,
Major climate data sets have underestimated the rate of global warming in the last 15 years owing largely to poor data...
The tsetse fly is best known as the vector for the trypanosome parasites that cause sleeping sickness and a disease in...
The National Institutes of Health is revising its "two strikes" rule, which allowed researchers only one chance to...
By stabilizing the components of retromers, molecular complexes that act like recycling bins in cells, a recently...
Fossil fuels power modern society by generating heat, but much of that heat is wasted. Semiconductor devices called...
Researchers are gaining insights into what made Supertyphoon Haiyan so powerful and devastating through post-storm...
Millions around the world got a first-hand look at what it was like to be in Tacloban while it was pummeled by...
- 24 April 2014 11:45 am , Vol. 344 , #6182
- About Us
A Metastasis Calling Card?
10 December 2002 (All day)
A perennial puzzle for cancer researchers is why some tumors spread to other parts of the body, or metastasize, while others don't. Because most cancer deaths result from metastases, answering this question could help doctors anticipate metastatic disease and help choose the optimal treatment. Now researchers have taken a small step in that direction: They've deciphered a genetic "signature" that, in several tumor samples, appears to predict whether a cancer will spread.
Tumor cells metastasize once they acquire certain genetic mutations. These might make a cell hardier in a foreign environment--say, when a breast cell relocates to bone--or more able to escape the primary tumor and survive while rushed through the bloodstream. But distinguishing between garden-variety cancer cells and the more cunning metastatic type has been tough.
In a recent attempt, oncologist Todd Golub of the Dana-Farber Cancer Institute in Boston, Massachusetts, and his colleagues collected gene expression profiles, taken from public databases, from 76 tumors. Sixty-four were from a primary site (although the team members didn't know whether those cancers had later metastasized), and 12 were from metastases. Because the metastatic and primary samples weren't from the same individuals, and because the samples were drawn from a hodgepodge of cancers (lung, breast, prostate, colorectal, uterus, and ovary), Golub didn't really expect to see anything interesting.
To the researchers' surprise, they found distinct patterns of expression among 17 genes. They were particularly intrigued to see that some primary tumors shared an expression pattern with the metastatic ones. Could these tumors be the ones that would spread? The group turned to more profiles: 78 breast cancer, 62 lung cancer, and 21 prostate cancer samples, all from primary tumors, and with follow-up information about whether they had metastasized. Although a bad outcome was possible without the gene expression pattern, patients with the genetic signature were found to survive for less time than those who didn't have it, they wrote in the 9 December online edition of Nature Genetics.
"This study has provided strong evidence demonstrating that the molecular signature of metastasis exists prominently in the primary tumor," says Mary Hendrix, a cancer researcher at the University of Iowa in Iowa City. But Hendrix stresses that the study needs to be repeated with a larger sample. Furthermore, she says, it would be nice to know the function of the 17 genes--a few of which had been previously linked to cancer--because it could help refine tumor treatments.